Position in CHRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,940,000
-$609,000 QoQ
Shares Held
2,100,000
0.0% QoQ
Ownership
1.36%
of shares outstanding
% of Portfolio
1.87%
of 13F equity value
Holder Rank
#9
of 145 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CM Management, LLC holds $37,311,100 across 18 Biotechnology names. CHRS ranks #3 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RIGL |
Rigel Pharmaceuticals Inc
|
250,000 | $9,780,000 | |
| 2 | RPRX |
Royalty Pharma plc
|
125,000 | $7,008,750 | |
| 3 | CHRS |
Coherus Oncology, Inc.
This page
|
2,100,000 | $2,940,000 | |
| 4 | COYA |
Coya Therapeutics, Inc.
|
400,000 | $2,340,000 | |
| 5 | ELDN |
Eledon Pharmaceuticals, Inc.
|
575,000 | $2,265,500 | |
| 6 | LTRN |
Lantern Pharma Inc.
|
500,000 | $2,085,000 | |
| 7 | IOVA |
Iovance Biotherapeutics, Inc.
|
450,000 | $1,872,000 | |
| 8 | AVIR |
Atea Pharmaceuticals, Inc.
|
355,000 | $1,650,750 |
All Filings in CHRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,940,000 | 2,100,000 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $3,549,000 | 2,100,000 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,982,000 | 2,100,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $3,444,000 | 2,100,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,644,750 | 2,250,000 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,733,032 | 2,147,500 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $2,829,000 | 2,050,000 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $2,080,000 | 2,000,000 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,903,000 | 1,100,000 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,390,000 | 1,000,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,743,920 | 824,000 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,049,520 | 548,000 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $1,921,500 | 450,000 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,368,000 | 200,000 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $1,386,000 | 175,000 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,922,000 | 200,000 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,448,000 | 200,000 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,936,500 | 150,000 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,995,000 | 125,000 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,008,750 | 125,000 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $1,383,000 | 100,000 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,095,750 | 75,000 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,042,800 | 60,000 | Shares | Sole | 2021-02-04 | |
| No filing history on record for this holder in this stock. | ||||||